Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2012 | 04:35am CEST

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
09/22 ASAHI KASEI : obtains license for bone cell therapy product
09/14 ASAHI KASEI : Patent Issued for Signal Output Circuit (USPTO 9755588)
09/11 ASAHI KASEI : Home Order Trends – August 2017
09/07 ASAHI KASEI : to expand capacity for Lamous™ microfiber suede
09/05 ASAHI KASEI : and Bluestar establish joint ventures for mPPE business in China
08/31 ASAHI KASEI : Patent Application Titled "Hall Electromotive Force Signal Detecti..
08/23 ASAHI KASEI : to construct a new plant for plastic compounds in China
08/17 ASAHI KASEI : MILITARY $48,767 Federal Contract Awarded to Zoll Medical
08/10 ASAHI KASEI : Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute
08/07 ASAHI KASEI : Demonstration of validation plant for DRC process to produce DPC, ..
More news
News from SeekingAlpha
01/19 Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
2016 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
Financials ( JPY)
Sales 2018 1 976 B
EBIT 2018 -
Net income 2018 123 B
Debt 2018 186 B
Yield 2018 1,77%
P/E ratio 2018 15,94
P/E ratio 2019 15,25
EV / Sales 2018 1,07x
EV / Sales 2019 1,00x
Capitalization 1 931 B
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 226  JPY
Spread / Average Target -11%
EPS Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP34.54%17 235
AIR LIQUIDE3.45%50 757
PRAXAIR, INC.17.75%39 634
SHIN-ETSU CHEMICAL CO LTD11.34%39 151
LYONDELLBASELL INDUSTRIES NV11.97%37 914
AIR PRODUCTS & CHEMICALS, INC.4.98%32 922